Swiss Life Asset Management Ltd Raises Holdings in HCA Healthcare, Inc. $HCA

Swiss Life Asset Management Ltd lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 35.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 43,371 shares of the company’s stock after acquiring an additional 11,373 shares during the period. Swiss Life Asset Management Ltd’s holdings in HCA Healthcare were worth $20,248,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of HCA. Sovran Advisors LLC boosted its position in HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after buying an additional 22 shares during the last quarter. Centerpoint Advisors LLC boosted its position in HCA Healthcare by 11.0% in the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after buying an additional 22 shares during the last quarter. Cary Street Partners Financial LLC boosted its position in HCA Healthcare by 3.9% in the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after buying an additional 22 shares during the last quarter. Plato Investment Management Ltd boosted its position in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares during the last quarter. Finally, Angeles Wealth Management LLC boosted its position in HCA Healthcare by 2.4% in the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after buying an additional 24 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 13,714 shares of company stock valued at $7,050,460. 1.50% of the stock is owned by insiders.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. KeyCorp dropped their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. The Goldman Sachs Group upped their price objective on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Royal Bank Of Canada lowered their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Robert W. Baird lowered their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Finally, JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a research report on Friday, February 20th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $517.82.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $426.58 on Tuesday. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The firm has a market capitalization of $94.63 billion, a price-to-earnings ratio of 14.67, a price-to-earnings-growth ratio of 1.38 and a beta of 1.18. The business’s 50 day moving average price is $487.44 and its 200-day moving average price is $486.55.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the business earned $6.45 EPS. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.